Results 211 to 220 of about 51,741 (305)
Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK) [PDF]
, 2022 David A. Jolliffe, Sian Faustini, Hayley Holt, Natalia Perdek, Sheena Maltby, Mohammad Talaei, Matthew Greenig, Giulia Vivaldi, Florence Tydeman, Jane Symons, Gwyneth A. Davies, Ronan A Lyons, Chris Griffiths, Frank Kee, Aziz Sheikh, Seif O. Shaheen, Alex Richter, Adrian R. Martineau +17 moreopenalex +1 more sourceBNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Nature, 2021 U. Şahin, A. Muik, I. Vogler, E. Derhovanessian, L. Kranz, M. Vormehr, Jasmin Quandt, Nicole Bidmon, Alexander Ulges, A. Baum, Kristen E. Pascal, D. Maurus, Sebastian Brachtendorf, Verena Lörks, Julian Sikorski, Peter Koch, R. Hilker, D. Becker, Ann-Kathrin Eller, J. Grützner, Manuel Tonigold, Carsten Boesler, Corinna Rosenbaum, L. Heesen, Marie-Cristine Kühnle, A. Poran, Jesse Z. Dong, U. Luxemburger, Alexandra Kemmer-Brück, D. Langer, M. Bexon, S. Bolte, T. Palanché, A. Schultz, S. Baumann, Azita J. Mahiny, G. Boros, J. Reinholz, G. Szabó, K. Karikó, P. Shi, Camila R. Fontes-Garfias, John L. Perez, Mark Cutler, David Cooper, C. Kyratsous, P. Dormitzer, K. Jansen, Ö. Türeci +48 moresemanticscholar +1 more sourceComparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2 [PDF]
, 2023 Enikő Szabó, Szabolcs Modok, Benedek Rónaszéki, Anna F. Farago, Nikolett Gémes, Lajos I. Nagy, László Hackler, Katalin Farkas, Patrícia Neuperger, József Á. Balog, Attila Balog, László G. Puskás, Gábor J. Szebeni +12 moreopenalex +1 more sourceAuthor Correction: Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile [PDF]
, 2022 Mónica L. Acevedo, Aracelly Gaete-Argel, Luis Alonso-Palomares, Marco Montes de, Andrés Bustamante, Aldo Gaggero, Fabio Paredes, Claudia P. Cortés, Sergio Pantano, Constanza Martínez-Valdebenito, Jenniffer Angulo, Nicole Le Corre, Marcela Ferrés, Marcelo A. Navarrete, Fernando Valiente‐Echeverría, Ricardo Soto‐Rifo +15 moreopenalex +1 more sourceEffectiveness of BNT162b2 against COVID-19 in adolescents
The Lancet Infectious Diseases, 2022 Powell, Annabel A, Kirsebom, Freja, Stowe, Julia, McOwat, Kelsey, Saliba, Vanessa, Ramsay, Mary E, Lopez-Bernal, Jamie, Andrews, Nick, Ladhani, Shamez N +8 moreopenaire +2 more sourcesSerum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination
Infectious Diseases and TherapyIntroduction Rare myocarditis and pericarditis cases have occurred in coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccine recipients. Troponin levels, a potential marker of myocardial injury, were assessed in healthy participants before and ...Timothy E. Albertson, Caitlin Hansen, Smiti Bihari, Juleen Gayed, Xia Xu, J. Abraham Simón-Campos, Michael E. Dever, Jose F. Cardona, Essack Mitha, Jeffrey B. Baker, Georgina Keep, Islamiat Oladipupo, Federico J. Mensa, Ye Feng, Hua Ma, Kenneth Koury, Susan Mather, Claudia Ana Ianos, Annaliesa S. Anderson, Özlem Türeci, Uǧur Şahin, William C. Gruber, Alejandra Gurtman, Charu Sabharwal, Nicholas Kitchin, the C4591031, C4591007 Clinical Trial Groups +25 moredoaj +1 more sourceBNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes [PDF]
, 2022 Abdul-Jawad, Sultan, Alaguthurai, Thanussuyah, Beatson, Richard, Doores, Katie J, Graham, Carl, Graham, Rosalind, Irshad, Sheeba, Kulasekararaj, Austin, Lechmere, Thomas, Patten, Piers Em, Vidler, Jennifer +10 morecore +4 more sources
